Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
Sanchez VA, Dinh PC Jr, Monahan PO, Althouse S, Rooker J, Sesso HD, Dolan ME, Weinzerl M, Feldman DR, Fung C, Einhorn LH, Frisina RD, Travis LB.
JAMA Oncol. 2024 Jul 1;10(7):912-922. doi: 10.1001/jamaoncol.2024.1233.
[New antilipemics: prospects].
Farnier M.
Therapie. 2003 Jan-Feb;58(1):97-105. doi: 10.2515/therapie:2003014.
Lipid Metabolism, Methylation Aberrant, and Osteoporosis: A Multi-omics Study Based on Mendelian Randomization.
Zhang Z, Duan Y, Huo J.
Calcif Tissue Int. 2024 Feb;114(2):147-156. doi: 10.1007/s00223-023-01160-6. Epub 2023 Dec 10.
Trends in epidemiology of dyslipidemias in India.
Sharma S, Gaur K, Gupta R.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S20-S28. doi: 10.1016/j.ihj.2023.11.266. Epub 2024 Feb 12.
Cerivastatin.
Cheng-Lai A.
Heart Dis. 2000 Jan-Feb;2(1):93-9.
Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
Weng S, Kai J, Akyea R, Qureshi N.
Lancet Public Health. 2019 May;4(5):e256-e264. doi: 10.1016/S2468-2667(19)30061-1.
The causal relationship between pure hypercholesterolemia and psoriasis: A bidirectional, two-sample Mendelian randomization study.
Bai R, Ren L, Guo J, Xian N, Luo R, Chang Y, Dai Y, Lei H, Zheng Y.
Skin Res Technol. 2023 Dec;29(12):e13533. doi: 10.1111/srt.13533.
Oxylanosterols as modifiers of cholesterol biosynthesis.
Trzaskos JM.
Prog Lipid Res. 1995;34(2):99-116. doi: 10.1016/0163-7827(94)00008-a.
Clinical pharmacokinetics of cerivastatin.
Mück W.
Clin Pharmacokinet. 2000 Aug;39(2):99-116. doi: 10.2165/00003088-200039020-00002.
Why Is Very High Cholesterol Content Beneficial for the Eye Lens but Negative for Other Organs?
Widomska J, Subczynski WK.
Nutrients. 2019 May 15;11(5):1083. doi: 10.3390/nu11051083.
